Get the Stockscreener App
2.58
16.23%
-0.50
After Hours:
2.32
-0.26
-10.08%
Dermata Therapeutics Inc Stock (DRMA) Forecast
The Dermata Therapeutics Inc (DRMA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.0566, representing a +173.51% increase from the current price of $2.58. The highest analyst price target is $7.1003, and the lowest is $7.013.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month DRMA Price Target
Average 11.20
(+333.98% Upside)
Is Dermata Therapeutics Inc (DRMA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.64 | Neutral |
| STOCH(9,6) | 53.11 | Neutral |
| STOCHRSI(14) | 64.90 | Neutral |
| MACD(12,26) | 0.0111 | Buy |
| ADX(14) | 20.97 | Neutral |
| William %R | -71.72 | Neutral |
| CCI(14) | 141.69 | Buy |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.336
Buy
|
2.3992
Buy
|
| MA20 |
2.234
Buy
|
2.3374
Buy
|
| MA50 |
2.4831
Buy
|
2.639
Sell
|
| MA100 |
3.4848
Sell
|
3.5148
Sell
|
| MA200 |
5.2378
Sell
|
5.5282
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, DRMA could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 5 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on DRMA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.64 indicates that DRMA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.11 indicates that DRMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.9 indicates that DRMA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.97 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 141.69 indicates that DRMA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term DRMA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Dermata Therapeutics Inc financial reports and earnings history, Dermata Therapeutics Inc (DRMA) stock could reach $48.03 by 2030, $19.11 by 2040 and $90.16 by 2050. See the projected annual prices until 2050 of the Dermata Therapeutics Inc stock below:
- Dermata Therapeutics Inc (DRMA) is expected to reach an average price of $83.34 in 2035, with a high prediction of $95.62 and a low estimate of $87.09. This indicates an $3,130% rise from the last recorded price of $2.58.
- Dermata Therapeutics Inc (DRMA) stock is projected to chart a bullish course in 2040, with an average price target of $16.10, representing an $523.88% surge from its current level. The forecast ranges from a conservative $16.14 to a sky-high $19.11.
- Our analysts predict Dermata Therapeutics Inc (DRMA) to jump 1,639% by 2045, soaring from $45.11 to an average price of $44.87, potentially reaching $49.03. While $45.11 is the low estimate, the potential upside is significant.
- Dermata Therapeutics Inc (DRMA) stock is expected to climb by 2050, reaching an average of $85.29, a $3,206% jump from its current level. However, a wide range of estimates exists, with high and low targets of $90.16 and $85.30, respectively, highlighting the market's uncertainty.
Dermata Therapeutics Inc Stock (DRMA) Year by Year Forecast
Dermata Therapeutics Inc Stock (DRMA) Price Forecast for 2026
The predicted value for Dermata Therapeutics Inc (DRMA) in 2026 is set at an average of $3.8358. Estimates vary from a peak of $7.495 to a trough of $0.1767, indicating an +48.68% surge from the present price of $2.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2026 | $7.013 | $7.013 | $7.1003 | +171.82% |
| March, 2026 | $6.1883 | $6.3083 | $6.6693 | +139.86% |
| April, 2026 | $5.6285 | $5.63 | $5.9746 | +118.16% |
| May, 2026 | $5.2982 | $5.3053 | $5.4065 | +105.36% |
| June, 2026 | $4.538 | $4.5455 | $4.8837 | +75.89% |
| July, 2026 | $3.7015 | $3.7323 | $4.257 | +43.47% |
| August, 2026 | $3.2267 | $3.2576 | $3.5287 | +25.07% |
| September, 2026 | $2.2994 | $2.3394 | $2.892 | -10.88% |
| October, 2026 | $1.6458 | $1.6607 | $2.1156 | -36.21% |
| November, 2026 | $0.955 | $0.9792 | $1.455 | -62.99% |
| December, 2026 | $0.4646 | $0.1767 | $0.7525 | -81.99% |
Dermata Therapeutics Inc Stock (DRMA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Dermata Therapeutics Inc (DRMA) is $22.74, with a high forecast of $30.22 and a low forecast of $15.25. This indicates an +781.31% increase from the last price of $2.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $11.89 | $15.25 | $22.22 | +360.97% |
| February, 2027 | $26.66 | $17.95 | $25.86 | +933.48% |
| March, 2027 | $23.65 | $27.11 | $27.22 | +816.55% |
| April, 2027 | $25.06 | $24.84 | $23.71 | +871.23% |
| May, 2027 | $28.80 | $24.79 | $26.52 | +1,016% |
| June, 2027 | $30.81 | $28.79 | $28.15 | +1,094% |
| July, 2027 | $30.65 | $30.78 | $30.22 | +1,088% |
| August, 2027 | $28.17 | $26.97 | $25.63 | +992.01% |
| September, 2027 | $26.62 | $26.16 | $26.09 | +931.65% |
| October, 2027 | $25.71 | $24.92 | $24.99 | +896.40% |
| November, 2027 | $22.53 | $22.80 | $24.80 | +773.09% |
| December, 2027 | $19.94 | $21.62 | $21.06 | +672.91% |
Dermata Therapeutics Inc Stock (DRMA) Price Forecast for 2028
In 2028, Dermata Therapeutics Inc (DRMA) is projected to reach an average price of $18.72, with a high projection of $25.22 and a low estimate of $12.21. This indicates an +625.46% rise from the last price of $2.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.84 | $20.57 | $25.22 | +940.24% |
| February, 2028 | $23.72 | $24.28 | $25.06 | +819.42% |
| March, 2028 | $21.86 | $22.27 | $22.95 | +747.27% |
| April, 2028 | $21.16 | $21.42 | $21.09 | +720.02% |
| May, 2028 | $22.29 | $21.09 | $22.06 | +763.95% |
| June, 2028 | $20.55 | $20.57 | $21.81 | +696.53% |
| July, 2028 | $19.18 | $18.90 | $19.77 | +643.46% |
| August, 2028 | $17.19 | $17.30 | $18.77 | +566.46% |
| September, 2028 | $16.19 | $16.19 | $16.78 | +527.34% |
| October, 2028 | $15.16 | $15.16 | $15.75 | +487.44% |
| November, 2028 | $13.45 | $13.46 | $14.64 | +421.29% |
| December, 2028 | $12.21 | $12.21 | $13.03 | +373.20% |
Dermata Therapeutics Inc Stock (DRMA) Price Forecast for 2029
The 2029 price forecast for Dermata Therapeutics Inc Stock (DRMA) is $25.32 on average, with a high prediction of $49.95 and a low estimate of $0.6784. This represents an +881.22% increase from the previous price of $2.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.60 | $10.84 | $11.81 | +310.98% |
| February, 2029 | $9.2886 | $9.454 | $10.12 | +260.02% |
| March, 2029 | $8.0239 | $8.0547 | $8.9367 | +211.00% |
| April, 2029 | $6.8544 | $6.8853 | $7.6774 | +165.67% |
| May, 2029 | $5.0587 | $5.0987 | $6.346 | +96.07% |
| June, 2029 | $3.7105 | $3.7254 | $4.7013 | +43.82% |
| July, 2029 | $2.325 | $2.3493 | $3.3461 | -9.88% |
| August, 2029 | $1.3136 | $0.6784 | $1.9488 | -49.08% |
| September, 2029 | $35.84 | $39.20 | $46.68 | +1,289% |
| October, 2029 | $49.55 | $41.72 | $49.12 | +1,821% |
| November, 2029 | $46.03 | $51.43 | $49.95 | +1,684% |
| December, 2029 | $46.75 | $46.88 | $45.63 | +1,712% |
Dermata Therapeutics Inc Stock (DRMA) Price Forecast for 2030
Dermata Therapeutics Inc Stock (DRMA) is expected to reach an average price of $42.12 in 2030, with a high forecast of $50.11 and a low forecast of $34.13. This signifies an +1,533% surge from the last price of $2.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $51.26 | $46.31 | $48.03 | +1,887% |
| February, 2030 | $50.94 | $49.26 | $48.77 | +1,874% |
| March, 2030 | $50.09 | $50.21 | $50.11 | +1,841% |
| April, 2030 | $46.91 | $46.05 | $44.37 | +1,718% |
| May, 2030 | $44.48 | $44.21 | $44.65 | +1,624% |
| June, 2030 | $42.88 | $42.27 | $42.69 | +1,562% |
| July, 2030 | $37.84 | $38.68 | $41.80 | +1,367% |
| August, 2030 | $35.55 | $37.23 | $37.20 | +1,278% |
| September, 2030 | $41.75 | $35.66 | $40.14 | +1,518% |
| October, 2030 | $37.78 | $38.50 | $39.63 | +1,364% |
| November, 2030 | $35.21 | $35.62 | $36.82 | +1,265% |
| December, 2030 | $33.81 | $34.13 | $34.27 | +1,211% |
2.09%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):